التغذية عند حديثي الولادة وعلاقتها باليرقان

American Academy of Pediatrics. (2022). Clinical practice guideline: Management of hyperbilirubinemia in the newborn infant. Pediatrics.

Diaz, M. (2025). Shedding light on neonatal hyperbilirubinemia. Hospital Pediatrics.

Isa, H. M., AlBuainain, N. Y., Bunajem, F. Y., Masood, A. S., & Bucheery, Y. A. (2022). Neonatal and maternal risk factors for indirect hyperbilirubinemia: A cross-sectional study. International Journal of Pediatrics.

Kemper, A. R., Newman, T. B., Slaughter, J. L., et al. (2022). Clinical practice guideline revision: Management of hyperbilirubinemia in newborn infants ≥35 weeks of gestation. Pediatrics.

Lin, Q., Zhu, D., Chen, C., Feng, Y., Shen, F., & Wu, Z. (2022). Risk factors for neonatal hyperbilirubinemia: A systematic review and meta-analysis. Translational Pediatrics.

Mohammad, K. I. S., et al. (2024). Maternal and neonatal factors associated with neonatal jaundice: A case-control study. British Journal of Midwifery.

Nshimiyumuremyi, E., et al. (2025). Maternal and fetal adverse outcomes associated with gestational diabetes. BMJ Open.

Par, E. J., & Hughes, C. A. (2023). Neonatal hyperbilirubinemia: Evaluation and treatment. American Family Physician.

Slusher, T. M., Zamora, T. G., Appiah, D., et al. (2023). Global perspectives on neonatal hyperbilirubinemia and its management. Pediatrics.

Wang, D., Zhou, X., Ning, J., He, F., Shi, J., & Jin, X. (2024). Risk factors for neonatal complications: A meta-analysis. BMC Endocrine Disorders.

Yang, F., Liu, H., & Ding, C. (2024). Gestational diabetes mellitus and neonatal outcomes: A systematic review and meta-analysis. Diabetology & Metabolic Syndrome.

Bertini, G., Dani, C., Tronchin, M., et al. (2001). Is breastfeeding really favoring early neonatal jaundice? Pediatrics, 107(5), E41.

Bhutani, V. K., Stark, A. R., Lazzeroni, L. C., et al. (2013). Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. Journal of Pediatrics, 162(3), 477–482.e471.

Boskabadi, H., Maamouri, G., Kiani, M. A., & Abdollahi, A. (2010). Evaluation of urinary tract infections following neonatal jaundice. Journal of Shahrekord University of Medical Sciences, 12(2), 95–100.

Boskabadi, H., & Navaei, M. (2011). Relationship between delivery type and jaundice severity among newborns referred to Ghaem Hospital within a 6-year period in Mashhad. Iranian Journal of Obstetrics, Gynecology & Infertility, 14(4), 15–21.

Chang, P. F., Lin, Y. C., Liu, K., Yeh, S. J., & Ni, Y. H. (2011). Risk of hyperbilirubinemia in breast-fed infants. Journal of Pediatrics, 159(4), 561–565.

Esmailepour-Zanjani, S., Safavi, M., Jalali, S., & Abyane, E. E. (2007). Incidence and associated factors of neonatal hyperbilirubinemia at Hedayat hospital. Journal of Shahid Beheshti School of Nursing and Midwifery, 17(59), 19–25. (Persian)

Flaherman, V. J., Gay, B., Scott, C., et al. (2012). Randomized trial comparing hand expression with breast pumping for mothers of term newborns feeding poorly. Archives of Disease in Childhood - Fetal and Neonatal Edition, 97(1), F18–F23.

Jangaard, K. A., Fell, D. B., Dodds, L., et al. (2008). Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of ≥325 µmol/L (≥19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000. Pediatrics, 122(1), 119–124.

Keren, R., Luan, X., Friedman, S., et al. (2008). A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics, 121(1), e170–e179.

Maisels, M. J., Clune, S., Coleman, K., et al. (2014). The natural history of jaundice in predominantly breastfed infants. Pediatrics, 134(2), e340–e345.

Tareq Alnnale. (2026). From Reactive to Proactive Governance: A Hybrid LSTM–Gradient Boosting Architecture for Real-Time Anomaly Signal Detection in Multi-Store Retail Supply Chain Decision Systems. Al-Farooq Journal of Sciences, 2(1), 987-1005.‏

Mateo, P. C., Lee, K. S., Barozzino, M., & Sgro, M. (2013). Management of neonatal jaundice varies by practitioner type. Canadian Family Physician, 59(8), e379–e386.

Moore, E. R., Bergman, N., Anderson, G. C., et al. (2016). Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.CD003519.pub4

Preer, G. L., & Philipp, B. L. (2011). Understanding and managing breast milk jaundice. Archives of Disease in Childhood - Fetal and Neonatal Edition, 96(6), F461–F466.

Sato, H., Uchida, T., Toyota, K., et al. (2013). Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding. Journal of Human Genetics, 58(1), 7–10.

Sato, H., Uchida, T., Toyota, K., et al. (2015). Association of neonatal hyperbilirubinemia in breast-fed infants with UGT1A1 or SLCOs polymorphisms. Journal of Human Genetics, 60(1), 35–40.

VanWagner, L. B., & Green, R. M. (2015). Evaluating elevated bilirubin levels in asymptomatic adults. JAMA, 313(5), 516–517.

Yang, W. C., Zhao, L. L., Li, Y. C., et al. (2013). Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatrics, 13, 145.